Standpoint Research Starts ANI Pharmaceuticals (ANIP) at Buy
Tweet
Share
E-mailGet Alerts ANIP Hot Sheet
Price: $79.20 -3.32%
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Join SI Premium – FREE
Standpoint Research initiated coverage on ANI Pharmaceuticals (NASDAQ: ANIP) with a Buy rating.
For an analyst ratings summary and ratings history on ANI Pharmaceuticals click here. For more ratings news on ANI Pharmaceuticals click here.
Shares of ANI Pharmaceuticals closed at $40.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts PI Industries Ltd (PI:IN) at Buy
- ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter
- Axis Bank Ltd. (AXSB:IN) PT Lowered to INR1,600 at HSBC
Create E-mail Alert Related Categories
New CoverageRelated Entities
Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
